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Critically ill children and those sustaining severe traumatic injuries are at higher risk for 
developing venous thromboembolism (VTE) than other hospitalized children. Multiple 
factors including the need for central venous catheters, immobility, surgical procedures, 
malignancy, and dysregulated inflammatory state confer this increased risk. As well as 
being at higher risk of VTE, this population is frequently at an increased risk of bleeding, 
making the decision of prophylactic anticoagulation even more nuanced. The use of 
pharmacologic and mechanical prophylaxis remains variable in this high-risk cohort. VTE 
pharmacologic prophylaxis is an accepted practice in adult trauma and intensive care to 
prevent VTE development and associated morbidity, but it is not standardized in critically 
ill or injured children. Given the lack of pediatric specific guidelines, prevention strategies 
are variably extrapolated from the successful use of mechanical and pharmacologic pro-
phylaxis in adults, despite the differences in developmental hemostasis and thrombosis 
risk between children and adults. Whether the burden of VTE can be reduced in the 
pediatric critically ill or injured population is not known given the lack of robust data. 
There are no trials in children showing efficacy of mechanical compression devices or 
prophylactic anticoagulation in reducing the rate of VTE. Risk stratification using clinical 
factors has been shown to identify those at highest risk for VTE and allows targeted 
prophylaxis. It remains unproven if such a strategy will mitigate the risk of VTE and its 
potential sequelae.
Keywords: venous thromboembolism, deep vein thrombosis, pediatric critical illness, pediatric trauma, child, 
prophylaxis
inTRODUCTiOn
Venous thromboembolism (VTE) diagnosis in hospitalized children appears to have increased mark-
edly over the past decade (1). Critically ill and/or severely injured children are at a disproportionately 
higher risk of VTE events due to the presence of multiple VTE risk factors (2, 3). Clinical diagnosis 
of VTE can be especially challenging in a critically ill and severely injured child as extremity swelling 
and erythema may be non-specific signs and self-reporting of pain is limited by sedation, immobility, 
and physical state. Hence, a high degree of suspicion is needed on the part of a clinician to perform 
imaging and diagnose VTE.
Table 1 | incidence of vTe in critically ill or injured children.a
Reference Design/data source Population vTe (N/total) vTe incidence (%)
Allen et al. (11) Retrospective, single center Trauma 22/1,934 1.1
Connelly et al. (5) Retrospective, NTDB data Trauma 1,141/536,423 0.2
Yen et al. (8) Retrospective, single center and NTDB data Trauma Single center: 49/17,366 0.3–0.4
NTDB 2011–2012: 
1,168/281,248
Carpenter et al. (22) Retrospective, single center ICU (bacteremia) 21/229 9.2
Arlikar et al. (16) Retrospective, single center, case-control, ICD-9 codes ICU 57/19,000 (est) 0.3
Harris and Lam (10) Retrospective, KID data Trauma (TBI) 267/58,529 0.5
Al Tassan et al. (19) Retrospective, single center ICU (CVC) 21/248 CVC 8.5
Van Arendonk et al. (6) Retrospective, NTDB data Trauma 1,655/402,329 0.4
Faustino et al. (18) Prospective, multicenter ICU (CVC) 16/101 15.8
Askegard-Giesmann et al. (7) Retrospective, multicenter, PHIS data Trauma 671/260,078 0.3
O’Brien et al. (12) Retrospective, multicenter, local trauma registries Trauma 15/1,706 0.9
Hanson et al. (14) Prospective, single center Trauma, ICU 3/169 1.7
Greenwald et al. (30) Retrospective, single center Trauma 3/1,782 0.2
Hanson et al. (21) Nested case–control, single center ICU (cardiac disease) 41/1,070 3.8
Higgerson et al. (17) Prospective, multicenter ICU 62/6,653 0.9
O’Brien and Candrilli (13) Retrospective, multicenter NTDB data Trauma, ICU 1,087/135,032 0.8
Hanson et al. (15) Nested case–control, single center Trauma, ICU 9/144 6.2
Hanslik et al. (20) Prospective, single center ICU (CVC and cardiac 
disease)
25/90 27.8
Candrilli et al. (9) Retrospective, multicenter, HCUP-KID data Trauma 648/240,387 0.3
Cyr et al. (3) Retrospective, single center, ICD-9 data Trauma, ICU 11/3,291 0.3
aAge <21 years, includes only studies published since 2006 with defined incidence of VTE in pediatric ICU or in trauma populations.
NTDB, National Trauma Data Bank; TBI, traumatic brain injury; CVC, central venous catheter; KID, Kids Inpatient Database; PHIS, pediatric health information system; VTE, venous 
thromboembolism; ICU, intensive care unit.
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In critically ill and injured adults, mechanical and pharma-
cologic prophylaxis is an accepted practice to mitigate VTE (4); 
however, this is not the case in children. In addition, VTE risk 
prediction and stratification remains a challenge and robust risk 
scoring systems remain elusive in children. Even if one were to 
develop the perfect risk screen, there are no data showing a ben-
efit from prophylaxis in critically ill children. Despite the paucity 
of evidence surrounding screening and prophylaxis, health-care 
providers are motivated to develop strategies to reduce the 
incidence of VTE in children. While mechanical prophylaxis is 
relatively risk free, pharmacologic prophylaxis may increase the 
bleeding risk in this group of patients. This review will summarize 
the epidemiology/incidence and current controversies in regards 
to VTE in critically ill and severely injured children.
inCiDenCe anD RiSK FaCTORS FOR vTe 
in CRiTiCallY ill OR inJUReD 
CHilDRen
An increase in the diagnosis for VTE has been reported for hospi-
talized children from 2001 to 2008 (1); however, it is not known if 
this increase is equivalent among the subpopulations of critically 
ill or injured children. The interpretation of reported rates of 
VTE is confounded by the lack of standard VTE screening or for 
diagnosis of VTE. The reported incidence of VTE in critically ill 
and/or severely injured children is summarized in Table 1. There 
is a wide variation in incidence based on the study design and the 
specific population included. For instance, the incidence of VTE 
in pediatric trauma ranges from 0.2 to 0.5% in large, retrospec-
tive studies of hospitalized children using databases (5–10), while 
higher rates of 0.9–1.1% were found in smaller studies using data 
from the patient records (11, 12). For injured children admitted 
to the intensive care unit (ICU), the incidence rate (0.3–6.2%) is 
higher especially in prospective studies (3, 13–15).
For the general pediatric ICU population, the incidence of 
VTE ranges 0.3–0.9% (16–22), with the higher incidence being 
reported from prospective studies. Specific subpopulations of 
critically ill children report higher incidence of VTE including 
those with central venous catheters (CVCs) (17–19), cardiac 
disease (20, 21), and bacteremia (22).
The risk factors for VTE in critically ill and/or severely injured 
children are summarized in Table 2. Critically ill and/or severely 
injured children are at a disproportionately higher risk of VTE 
events than any other cohort of children due to the presence of 
multiple risk factors: including endothelial injury from trauma, 
CVC placement, and/or operative procedures; alterations in 
blood flow from immobility and poor perfusion requiring 
inotropic support; and hypercoagulability from sepsis, trauma, 
blood transfusion, or other dysregulated inflammatory states (see 
Table 2). The exact contribution of each of these factors is unclear; 
however, the presence of a CVC is probably the most important 
risk factor for VTE in this cohort of children. Most, but not all, 
studies found increasing age to be a risk factor for VTE in injured 
and critically ill children (see Table 2). In studies that performed 
a separate analysis for infants, <1 year of age was also associated 
with increased risk. For trauma patients, the risk of VTE appears 
to increase with higher injury severity scores (ISS) (see Table 2).
Table 2 | Risk factors for vTe in critically ill or injured children.
Reference age (years) CvC Surgery illness/injury severity Other risk factors
Allen et al. (11) >13, OR 9.2 OR 4.4 Orthopedic, OR 6.8 N/A MVI, OR 15.4
Harris and Lam (10) >15, OR 3.7 OR 3.0 Orthopedic, OR 2.44 N/A Ventilator, OR 1.9
Cranial, OR 1.78 Tracheostomy, OR 2.3
NAT, OR 2.8
Yen et al. (8) 13–15, OR 3.81 N/A OR 8.0 ISS 9–15, OR 4.1 GCS < 9, OR 2.8
>16, OR 5.22 ISS 16–24, OR 10.8 Transfusion, OR 2.8
ISS > 25, OR 15.7
Carpenter et al. (22) NS NS N/A N/A CRP > 20, OR 4.2
Hg nadir < 9, OR 5.2
Connelly et al. (5) 13–15, OR 1.3 OR 1.9 OR 4.5 N/A ICU, OR 5.5
16–17, OR 1.7 Ventilator, OR 2.6
GCS < 9, OR 1.4
Pelvic/LE fx, OR 1.4
Arlikar et al. (16) NS OR 26 NS N/A Infection, OR 3.4
Van Arendonk et al. (6) 13–15, OR 2.0 OR 1.3 OR 3.8 ISS 9–15, OR 3.9 Ventilator, OR 2.5
>16, OR 3.8 ISS 16–24, OR 5.9 Transfusion, OR 1.5
ISS > 25, OR 7.2 GCS < 9, OR 1.3
Faustino et al. (18) >13, OR 14.1 All Postop-NS PIM2-NS
Askegard-Giesmann et al. (7) N/A OR 8.0 N/A N/A ICU OR, 3.7
Pelvic fx OR, 1.6
Hanson et al. (21) NS OR 1.1 N/A PRISM3-NS Single ventricle, OR 11.2
Higgerson et al. (17) N/A OR 9.3 N/A N/A
O’Brien and Candrilli (13) <1, OR 1.75 OR 1.8 Cranial, OR 1.8 N/A TBI, OR 1.33
14–17, OR 2.34 Open LE, OR 1.1 LE fx, OR 1.8
Vascular, OR 2.8 Pelvic fx, OR 1.2
Hanson et al. (15) NS OR 19 N/A NS PN, OR 20.8
NMB, OR 10.0
Inotropes, OR 10
Candrilli et al. (9) NA NA NA ISS 9–15, OR 2.1
ISS 16–25, OR 2.5
ISS > 25, OR 3.5
Cyr et al. (3) 15–18, OR 19.5 OR 64 Chest, OR 6.9 ISS > 8, OR 5.3 SCI, OR 37.4
OR, adjusted odds ratio; NS, not significant; NA, not analyzed; MVI, motor vehicle injury; ISS, injury severity score; NAT, non-accidental trauma; CRP, C-reactive protein; Hg, 
hemoglobin; CVC, central venous catheter; LE fx, lower extremity fracture; GCS, Glasgow Coma Scale; PIM2, paediatric index of mortality 2; PRISM3, pediatric risk of mortality 
score; TBI, traumatic brain injury; NMB, neuromuscular blockade; PN, parenteral nutrition; SCI, spinal cord injury; ICU, intensive care unit.
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Overall interpretation and generalizability of data in regards 
to incidence and risk factors is limited, given the significant dif-
ferences in the population included and study design. Several, 
recent, large studies in children have used diagnostic codes 
for the identification of VTE (5, 6). Using diagnostic codes for 
identification of pediatric VTE has a low specificity and sensitiv-
ity (23). Hence, misidentification of children with and without 
VTE could result in differences in incidence rates and risk 
factors. Likewise, studies with smaller numbers of patients may 
fail to identify significant risk factors. Despite these limitations 
in study populations and methodologies, the incidence of VTE 
appears to increase in patients with multiple risk factors, with 
the presence of a CVC being the most important risk factor in 
critically ill and/or injured patients. Certain subpopulations 
of critically ill children have a greater risk for VTE, with an 
incidence of VTE >1%.
PRevenTiOn OF vTe in CRiTiCallY ill 
OR inJUReD CHilDRen
Efforts for prevention of VTE in critically ill or injured patients 
hinge on early mobilization and the use of mechanical and/or 
pharmacologic prophylaxis. Mechanical prophylaxis includes the 
use of sequential compression devices (SCD) or graduated com-
pression stockings, both of which are limited by size and cannot 
be used in smaller children and on injured extremities. There are 
no pediatric studies showing efficacy of mechanical prophylaxis 
in preventing VTE.
There is little evidence to guide the use of pharmacologic 
thromboprophylaxis in critically ill and injured children. 
Published pediatric guidelines are based on weak evidence 
and recommend against the use of pharmacologic prophylaxis 
except in children with cyanotic congenital heart disease, 
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dilated cardiomyopathy, cavopulmonary anastomosis, end-
stage renal disease, and primary pulmonary hypertension 
(24). A recently published consensus of experts in regards 
to pediatric trauma recommended against prophylaxis in 
children <12 years of age and gave a strong recommendation 
for pharmacologic prophylaxis in patients with a history of 
VTE, while a weak recommendation for patients with CVCs 
(25). Given the lack of data, it is not surprising that there is a 
wide variation in thromboprophylactic practices in critically ill 
children as shown in the PROTRACT study (26). This global 
point-prevalence study clearly demonstrated that the use of 
both mechanical and pharmacologic prophylaxes was center 
dependent with a wide variation in the use of prophylaxis. Data 
were collected on the type of pharmacologic thromboprophy-
laxis used in the ICU including aspirin, low-molecular-weight 
heparin, IV unfractionated heparin (UFH), subcutaneous 
UFH, warfarin, and clopidogrel. Aspirin was the most com-
monly used agent (143 of 308 patients, 46.4%), primarily 
because of patients with congenital heart disease. LMWH, 
almost exclusively enoxaparin, was the next most commonly 
used agent (113 of 308 patients, 36.7%). Warfarin was rarely 
used in the ICU setting (26).
Critically ill and/or injured children represent a high-risk 
cohort for VTE, especially in the setting of CVCs, and may 
merit from thromboprophylaxis. This is especially true as 
patients approach adulthood wherein heparin-based prophy-
laxis regimens have been shown to be effective in preventing 
VTE in critically ill adults (4). Whether such strategies are of 
benefit in critically ill and/or injured children remain unproven. 
However, a standardized systematic approach to VTE preven-
tion may result in a reduction in VTE. This was demonstrated 
in a single-center study in the setting of pediatric trauma where 
a reduction in incidence of VTE was noted after implementation 
of standardized thromboprophylaxis guidelines (14). Notably 
in this study, the reduced incidence of VTE was not associated 
with an increase in pharmacologic prophylaxis. The authors 
speculate that the decrease in VTE was a result of standardized, 
focused pharmacologic prophylaxis to those patients at high risk 
for VTE.
Pharmacologic prophylaxis should be instituted thought-
fully especially in patients at high risk for bleeding. There are 
minimal data on bleeding in the setting of pharmacologic 
prophylaxis for VTE in the critical care or trauma setting in 
pediatrics. In a multicenter review of trauma registry data to 
assess pharmacologic prophylaxis, the rate of major bleeding 
was 0.3% (12). However, single-center data demonstrated a 
higher rate of 4% in hospitalized pediatric patients receiving 
pharmacologic prophylaxis (27). A recent prospective obser-
vational study of hospitalized children receiving prophylactic 
anticoagulation showed a similar incidence of major bleeding 
especially in patients following orthopedic surgery (28). Taken 
together, the data demonstrate a low but definite risk of bleed-
ing children receiving pharmacologic prophylaxis. Hence, it is 
imperative that any preventive strategy utilizing pharmacologic 
prophylaxis account for the bleeding risk, especially in a high 
bleeding-risk cohort, such as children who are critically ill or 
severely injured.
In summary, VTE prevention in critically ill and/or injured 
children needs a standardized approach with VTE risk stratifica-
tion. Interventions should include early mobilization and removal 
of CVCs alongside mechanical and pharmacologic prophylaxes, 
especially in children >12 years of age.
PReDiCTinG vTe RiSK in CHilDRen 
aFTeR TRaUMa
Recently, two scoring systems to predict the risk of VTE in 
children hospitalized after trauma have been developed (5, 8). 
Both studies used the National Trauma Data Bank to derive and 
validate the VTE risk score over similar time periods. The model 
from Connelly et al. had good performance with an area under 
the curve of 93–94% (5). This model incorporated 10 VTE risk 
factors: age (increased risk for <1  year and adolescence), sex, 
Glasgow Coma Scale (GCS), CVC, intubation, blood transfusion, 
ICU admission, major surgery, pelvic fracture, and lower extrem-
ity fracture. Varying points for each risk factor are summed for 
a total score. Categorical risk was assigned based on this score: 
low risk (VTE incidence <1%), medium risk (VTE incidence 
1–5%), and high risk (VTE incidence >5%). The authors suggest 
a potential management strategy to implement screening ultra-
sounds and SCD for the medium-risk group, with the addition of 
pharmacologic prophylaxis for the high-risk group. By contrast, 
Yen et al. used a combination of local trauma registry data and 
the national trauma data bank for development and validation of 
a VTE risk score model with good performance as shown by the 
area under curve of 91% (8). The preferred model incorporates 
six risk factors, for which varying points are accumulated: older 
age, GCS, ISS, blood transfusion, intubation, and major surgery. 
CVC was not analyzed as a risk factor for the model. A score >17 
is associated with VTE risk >2%, referenced as a threshold for 
prophylaxis.
These studies provide the framework to convert epidemiologic 
risk factors into tools clinicians can use to predict the overall 
VTE risk for their injured patient. Both studies recognize the 
limitations of the national trauma database: surveillance bias, no 
temporal association of risks (intubation, surgery, and transfu-
sion) with the development of VTE, and the confounding effect of 
variable use of thromboprophylaxis. The rare occurrence of VTE 
in the overall hospitalized pediatric trauma population makes 
large database studies necessary to provide adequate power of 
associated risks, with the risks studied limited to those captured 
in the database. As injured children in the ICU have a higher VTE 
rate compared to the overall hospitalized children after trauma, 
this high-risk population may be appropriate to prospectively 
validate and refine an optimal VTE prediction tool.
FUTURe DiReCTiOnS
The ever-increasing medical complexity of critically ill and 
injured children implies that the risk of VTE will continue to be 
present especially in the setting of CVCs. Hence, standardized risk 
prediction and stratification will be the key to implementing any 
thromboprophylactic strategy. Validation of risk prediction tools 
will be challenging given the low overall incidence for VTE in 
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children. Currently, most risk assessment algorithms use clinical 
variables, and whether the addition of biomarkers bolsters their 
performance remains unclear. A recent prospective study in criti-
cally ill children with CVCs showed an association between factor 
VIII activity and catheter-related thrombosis (29).
Even with the ideal risk prediction tool, the appropriate 
interventions to prevent VTE are unknown. Hence, there is a 
pressing need to evaluate the efficacy of interventions in prevent-
ing VTE in children, including pharmacologic or mechanical 
prophylaxis, early ICU rehabilitation, and increased mobility. 
Given the low incidence of VTE in children, focusing on the 
subpopulations of critically ill or injured children at highest risk 
for VTE, including those with CVCs, will optimize the results 
of any clinical trial.
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